AQR CAPITAL MANAGEMENT LLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1167557 Greenwich, CT

Position in ALLO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,062,857

+$4,104,792 QoQ

Shares Held

2,484,780

+73.9% QoQ

Ownership

0.720%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,607,351,941 across 214 Biotechnology names. ALLO ranks #51 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,231,008	$951,126,014
2	EXEL	Exelixis, Inc.	13,095,741	$561,676,326
3	INCY	Incyte Corp	5,807,930	$546,642,368
4	BMRN	Biomarin Pharmaceutical Inc	7,676,541	$433,647,798
5	ALNY	Alnylam Pharmaceuticals, Inc.	913,104	$302,118,715
6	JAZZ	Jazz Pharmaceuticals plc	1,338,458	$253,035,481
7	RPRX	Royalty Pharma plc	3,782,038	$181,424,357
8	ROIV	Roivant Sciences Ltd.	5,946,858	$164,727,963

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,062,857	2,484,780	+73.9%	Shares	Other	2026-05-15
2025-12-31	$1,958,065	1,429,247	-22.9%	Shares	Other	2026-02-17
2025-09-30	$2,298,404	1,853,554	+2199.0%	Shares	Other	2025-11-14
2025-06-30	$91,103	80,624	+38.5%	Shares	Other	2025-08-14
2025-03-31	$85,003	58,223	+73.3%	Shares	Other	2025-05-15
2024-09-30	$94,048	33,589	+23.1%	Shares	Defined	2024-11-14
2024-06-30	$63,578	27,287	-63.0%	Shares	Defined	2024-08-14
2022-03-31	$671,561	73,717	+155.2%	Shares	Defined	2022-05-16
2021-12-31	$430,964	28,885	+42.3%	Shares	Defined	2022-02-14
2021-09-30	$521,555	20,294	-44.7%	Shares	Defined	2021-11-15
2021-06-30	$957,579	36,717	+328.1%	Shares	Defined	2021-08-16
2020-09-30	$323,400	8,576	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.